Education News and Research

RSS

Drugs approved for breast cancer treatment are effective and well tolerated in men

There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two further studies to be reported at ESMO 2018.

23 Oct 2018

Life skills program benefits adolescent girl refugees in Sub-Saharan Africa

A yearlong program for adolescent girl refugees in Sub-Saharan Africa successfully promoted healthy transitions to adulthood within the evaluation period, according to the results of randomized controlled trials in Ethiopia and the Democratic Republic of Congo.

23 Oct 2018

Jean Mayer Prize for Excellence in Nutrition Science and Policy awarded to individuals, organizations

The Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University has awarded the school's inaugural $100,000 Jean Mayer Prize for Excellence in Nutrition Science and Policy to two individuals and two organizations for their collective efforts to raise awareness of the risks of diet-related disease and advocacy for policies that champion better nutrition for younger generations.

23 Oct 2018

Study: 12% of frequent marijuana smokers experience cannabis withdrawal syndrome

As the number of Americans who regularly use cannabis has climbed, so too has the number of those experiencing cannabis withdrawal symptoms.

23 Oct 2018

New 17-item questionnaire may help detect GI disorders in children with autism

Anger, aggression, and other troubling behavior problems in kids with autism are often treated as psychological issues, but in many cases the problems can be traced to gastrointestinal distress.

23 Oct 2018

Map of human liver cells reveals molecular make-up of individual cells

A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.

From 10x Genomics, Inc. 23 Oct 2018

Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.

23 Oct 2018

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

A new program project grant from the National Cancer Institute will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor T cell therapy at fighting solid tumors.

23 Oct 2018

Volunteering for peer counseling programs benefits people with lupus

Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.

23 Oct 2018

New analysis reveals preliminary evidence for use of board games to improve health-related knowledge

Board games can engage patients in play and fantasy, and by enabling face-to-face interaction, can help educate patients on health-related knowledge and behaviors.

23 Oct 2018

Research offers new hope to men who received childhood cancer treatment

Researchers have discovered a way to grow human stem cells destined to become mature sperm in an effort to provide fertility options later in life to males who are diagnosed with cancer and undergo chemotherapy and radiation as children.

22 Oct 2018

Study: Targeting specific genomic mutation in breast cancer improves survival

Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival, according to late-breaking results reported at ESMO 2018.

22 Oct 2018

Stress related to social stigma negatively impacts mental health of autistic people

Stress related to social stigma may be the reason why autistic people experience more mental health problems than the general population, dispelling past theories that the condition itself is the origin of such distress.

22 Oct 2018

Targeted drug and hormone therapy combination extends breast cancer survival

Combining a targeted drug with hormone therapy substantially extends survival for women with advanced breast cancer, a major clinical trial has found.

22 Oct 2018

Study findings could set new standard of care for advanced anal cancer

A new approach to treating advanced anal cancer is safer and more effective than the most widely used current treatment, according to the first ever randomized clinical trial in this group of patients.

22 Oct 2018

Educational initiatives needed to improve knowledge about biosimilars in oncology

Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines - but they are also expensive.

22 Oct 2018

HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study

A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers caused by the human papillomavirus than Hispanics from the general population.

22 Oct 2018

Study highlights existence of barriers to early clinical trial access for adolescents and young adults

Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and pediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.

22 Oct 2018

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.

22 Oct 2018

Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer

Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with a nine-week course of adjuvant trastuzumab compared to those treated for one year, according to a subgroup analysis of the Short-HER trial reported at ESMO 2018 Congress in Munich.

22 Oct 2018

Education News and Research

Drugs approved for breast cancer treatment are effective and well tolerated in men

Life skills program benefits adolescent girl refugees in Sub-Saharan Africa

Jean Mayer Prize for Excellence in Nutrition Science and Policy awarded to individuals, organizations

Study: 12% of frequent marijuana smokers experience cannabis withdrawal syndrome

New 17-item questionnaire may help detect GI disorders in children with autism

Map of human liver cells reveals molecular make-up of individual cells

Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Volunteering for peer counseling programs benefits people with lupus

New analysis reveals preliminary evidence for use of board games to improve health-related knowledge

Research offers new hope to men who received childhood cancer treatment

Study: Targeting specific genomic mutation in breast cancer improves survival

Stress related to social stigma negatively impacts mental health of autistic people

Targeted drug and hormone therapy combination extends breast cancer survival

Study findings could set new standard of care for advanced anal cancer

Educational initiatives needed to improve knowledge about biosimilars in oncology

HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study

Study highlights existence of barriers to early clinical trial access for adolescents and young adults

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics